Apellis Pharmaceuticals I... (APLS)

AI Score

Unlock

18.20

0.04 (0.22%)

At close: Apr 17, 2025, 3:59 PM

18.15

-0.27%

Pre-market: Apr 21, 2025, 06:07 AM EDT

Dividends

No dividend history available for Apellis Pharmaceuticals Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

APLS News

2 weeks ago · APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag - zacks.com
2 weeks ago · FDA Reviews Kidney Disease Drug From Apellis Pharmaceuticals - benzinga.com
1 month ago · Apellis Pharmaceuticals: A Mixed Bag - seekingalpha.com
1 month ago · Apellis Lead Drug Pegcetacoplan Represents Differentiated Asset: JP Morgan Analyst - benzinga.com
1 month ago · Apellis Q4 Loss Narrower Than Expected, Syfovre Sales Drive Revenues - zacks.com
1 month ago · Apellis Pharmaceuticals, Inc. (APLS) Q4 2024 Earnings Call Transcript - seekingalpha.com
1 month ago · Compared to Estimates, Apellis Pharmaceuticals (APLS) Q4 Earnings: A Look at Key Metrics - zacks.com
1 month ago · Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Loss, Tops Revenue Estimates - zacks.com
1 month ago · Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - zacks.com
3 months ago · Bronstein, Gewirtz & Grossman, LLC Is Investigating Apellis Pharmaceuticals, Inc. (APLS) And Encourages Shareholders to Connect - accessnewswire.com